25 XP   0   0   10

China Resources Boya Bio pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse China Resources Boya Bio pharmaceutical Group Co Ltd together

PenkeI guess you are interested in China Resources Boya Bio pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of China Resources Boya Bio pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about China Resources Boya Bio pharmaceutical Group Co Ltd

I send you an email if I find something interesting about China Resources Boya Bio pharmaceutical Group Co Ltd.

Quick analysis of China Resources Boya Bio pharmaceutical Group Co Ltd (30 sec.)










What can you expect buying and holding a share of China Resources Boya Bio pharmaceutical Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
85.0%

What is your share worth?

Current worth
¥14.52
Expected worth in 1 year
¥14.59
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
¥0.07
Return On Investment
0.2%

For what price can you sell your share?

Current Price per Share
¥30.99
Expected price per share
¥29.06 - ¥32.46
How sure are you?
50%

1. Valuation of China Resources Boya Bio pharmaceutical Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥30.99

Intrinsic Value Per Share

¥5.94 - ¥6.49

Total Value Per Share

¥20.45 - ¥21.01

2. Growth of China Resources Boya Bio pharmaceutical Group Co Ltd (5 min.)




Is China Resources Boya Bio pharmaceutical Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$991.9m$37.6m3.7%

How much money is China Resources Boya Bio pharmaceutical Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$8.2m$14.9m-$6.7m-82.0%
Net Profit Margin3.6%15.5%--

How much money comes from the company's main activities?

3. Financial Health of China Resources Boya Bio pharmaceutical Group Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#56 / 1016

Most Revenue
#107 / 1016

Most Profit
#104 / 1016

Most Efficient
#147 / 1016

What can you expect buying and holding a share of China Resources Boya Bio pharmaceutical Group Co Ltd? (5 min.)

Welcome investor! China Resources Boya Bio pharmaceutical Group Co Ltd's management wants to use your money to grow the business. In return you get a share of China Resources Boya Bio pharmaceutical Group Co Ltd.

What can you expect buying and holding a share of China Resources Boya Bio pharmaceutical Group Co Ltd?

First you should know what it really means to hold a share of China Resources Boya Bio pharmaceutical Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of China Resources Boya Bio pharmaceutical Group Co Ltd is ¥30.99. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of China Resources Boya Bio pharmaceutical Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in China Resources Boya Bio pharmaceutical Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥14.52. Based on the TTM, the Book Value Change Per Share is ¥0.02 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of China Resources Boya Bio pharmaceutical Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.06-0.2%0.020.1%0.040.1%0.030.1%0.020.1%
Usd Book Value Change Per Share-0.07-0.2%0.000.0%0.030.1%0.050.2%0.040.1%
Usd Dividend Per Share0.000.0%0.000.0%0.010.0%0.000.0%0.010.0%
Usd Total Gains Per Share-0.07-0.2%0.000.0%0.040.1%0.050.2%0.050.2%
Usd Price Per Share4.65-4.70-4.63-4.62-5.62-
Price to Earnings Ratio-18.74-16.24-29.55-49.34-92.49-
Price-to-Total Gains Ratio-67.42-137.81-298.76-163.38-278.87-
Price to Book Ratio2.32-2.30-2.36-3.29-10.13-
Price-to-Total Gains Ratio-67.42-137.81-298.76-163.38-278.87-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.282818
Number of shares233
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.05
Usd Total Gains Per Share0.000.05
Gains per Quarter (233 shares)0.5712.31
Gains per Year (233 shares)2.3049.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102-844539
205-689188
307-412136137
409-216181186
5011019227235
6014223272284
7016427317333
8018631363382
9021835408431
100231039453480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%39.01.00.097.5%47.01.00.097.9%
Book Value Change Per Share3.01.00.075.0%11.01.00.091.7%17.03.00.085.0%35.05.00.087.5%41.07.00.085.4%
Dividend per Share0.00.04.00.0%8.00.04.066.7%16.00.04.080.0%34.00.06.085.0%42.00.06.087.5%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%18.02.00.090.0%38.02.00.095.0%46.02.00.095.8%

Fundamentals of China Resources Boya Bio pharmaceutical Group Co Ltd

About China Resources Boya Bio pharmaceutical Group Co Ltd

China Resources Boya Bio-pharmaceutical Group Co., Ltd. engages in the blood products, and biochemical and chemical drugs businesses in China and internationally. It offers blood products comprising human fibrinogen, intravenous human immunoglobulin, rabies immunoglobulin, human albumin, and human immunoglobulin; non-blood products, including metformin hydrochloride enteric-coated tablets, pioglitazone hydrochloride dispersible tablets, glipizide tablets, glimepiride tablets, pioglitazone hydrochloride dispersible tablets, simvastatin tablets, and calcium dobesilate capsules. The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co., Ltd. The company was founded in 1993 and is based in Fuzhou, China.

Fundamental data was last updated by Penke on 2024-04-16 13:54:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of China Resources Boya Bio pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit China Resources Boya Bio pharmaceutical Group Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare China Resources Boya Bio pharmaceutical Group Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -49.1% means that ¥-0.49 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of China Resources Boya Bio pharmaceutical Group Co Ltd:

  • The MRQ is -49.1%. The company is making a huge loss. -2
  • The TTM is 3.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ-49.1%TTM3.6%-52.7%
TTM3.6%YOY15.5%-11.8%
TTM3.6%5Y11.2%-7.6%
5Y11.2%10Y18.1%-6.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-49.1%-197.2%+148.1%
TTM3.6%-210.4%+214.0%
YOY15.5%-279.3%+294.8%
5Y11.2%-436.8%+448.0%
10Y18.1%-599.3%+617.4%
1.1.2. Return on Assets

Shows how efficient China Resources Boya Bio pharmaceutical Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare China Resources Boya Bio pharmaceutical Group Co Ltd to the Biotechnology industry mean.
  • -2.9% Return on Assets means that China Resources Boya Bio pharmaceutical Group Co Ltd generated ¥-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of China Resources Boya Bio pharmaceutical Group Co Ltd:

  • The MRQ is -2.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-2.9%TTM0.7%-3.6%
TTM0.7%YOY1.4%-0.7%
TTM0.7%5Y1.4%-0.7%
5Y1.4%10Y2.1%-0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.9%-13.6%+10.7%
TTM0.7%-12.9%+13.6%
YOY1.4%-11.9%+13.3%
5Y1.4%-14.2%+15.6%
10Y2.1%-16.2%+18.3%
1.1.3. Return on Equity

Shows how efficient China Resources Boya Bio pharmaceutical Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare China Resources Boya Bio pharmaceutical Group Co Ltd to the Biotechnology industry mean.
  • -3.1% Return on Equity means China Resources Boya Bio pharmaceutical Group Co Ltd generated ¥-0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of China Resources Boya Bio pharmaceutical Group Co Ltd:

  • The MRQ is -3.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 0.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-3.1%TTM0.8%-3.9%
TTM0.8%YOY1.5%-0.7%
TTM0.8%5Y1.7%-1.0%
5Y1.7%10Y2.6%-0.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.1%-17.0%+13.9%
TTM0.8%-16.1%+16.9%
YOY1.5%-15.4%+16.9%
5Y1.7%-20.0%+21.7%
10Y2.6%-21.1%+23.7%

1.2. Operating Efficiency of China Resources Boya Bio pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient China Resources Boya Bio pharmaceutical Group Co Ltd is operating .

  • Measures how much profit China Resources Boya Bio pharmaceutical Group Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare China Resources Boya Bio pharmaceutical Group Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of China Resources Boya Bio pharmaceutical Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM9.8%-9.8%
TTM9.8%YOY18.3%-8.5%
TTM9.8%5Y15.3%-5.5%
5Y15.3%10Y9.4%+5.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM9.8%-224.4%+234.2%
YOY18.3%-288.4%+306.7%
5Y15.3%-475.2%+490.5%
10Y9.4%-624.7%+634.1%
1.2.2. Operating Ratio

Measures how efficient China Resources Boya Bio pharmaceutical Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.08 means that the operating costs are ¥1.08 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of China Resources Boya Bio pharmaceutical Group Co Ltd:

  • The MRQ is 1.080. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.245. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.080TTM1.245-0.165
TTM1.245YOY1.265-0.020
TTM1.2455Y1.263-0.018
5Y1.26310Y0.858+0.405
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0802.997-1.917
TTM1.2453.247-2.002
YOY1.2653.766-2.501
5Y1.2635.675-4.412
10Y0.8587.857-6.999

1.3. Liquidity of China Resources Boya Bio pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if China Resources Boya Bio pharmaceutical Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 14.08 means the company has ¥14.08 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of China Resources Boya Bio pharmaceutical Group Co Ltd:

  • The MRQ is 14.082. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.006. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ14.082TTM11.006+3.076
TTM11.006YOY8.955+2.051
TTM11.0065Y6.305+4.701
5Y6.30510Y3.410+2.894
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.0823.930+10.152
TTM11.0064.251+6.755
YOY8.9555.436+3.519
5Y6.3056.045+0.260
10Y3.4106.363-2.953
1.3.2. Quick Ratio

Measures if China Resources Boya Bio pharmaceutical Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare China Resources Boya Bio pharmaceutical Group Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 7.83 means the company can pay off ¥7.83 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of China Resources Boya Bio pharmaceutical Group Co Ltd:

  • The MRQ is 7.826. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.507. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.826TTM6.507+1.319
TTM6.507YOY6.160+0.348
TTM6.5075Y3.414+3.093
5Y3.41410Y2.212+1.202
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.8263.629+4.197
TTM6.5074.065+2.442
YOY6.1605.397+0.763
5Y3.4145.993-2.579
10Y2.2126.277-4.065

1.4. Solvency of China Resources Boya Bio pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of China Resources Boya Bio pharmaceutical Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare China Resources Boya Bio pharmaceutical Group Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.06 means that China Resources Boya Bio pharmaceutical Group Co Ltd assets are financed with 6.5% credit (debt) and the remaining percentage (100% - 6.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of China Resources Boya Bio pharmaceutical Group Co Ltd:

  • The MRQ is 0.065. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.079. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.065TTM0.079-0.014
TTM0.079YOY0.090-0.010
TTM0.0795Y0.158-0.079
5Y0.15810Y0.163-0.005
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0650.332-0.267
TTM0.0790.334-0.255
YOY0.0900.268-0.178
5Y0.1580.366-0.208
10Y0.1630.390-0.227
1.4.2. Debt to Equity Ratio

Measures if China Resources Boya Bio pharmaceutical Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare China Resources Boya Bio pharmaceutical Group Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 6.9% means that company has ¥0.07 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of China Resources Boya Bio pharmaceutical Group Co Ltd:

  • The MRQ is 0.069. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.087. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.069TTM0.087-0.017
TTM0.087YOY0.100-0.013
TTM0.0875Y0.200-0.114
5Y0.20010Y0.212-0.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0690.381-0.312
TTM0.0870.390-0.303
YOY0.1000.334-0.234
5Y0.2000.434-0.234
10Y0.2120.466-0.254

2. Market Valuation of China Resources Boya Bio pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings China Resources Boya Bio pharmaceutical Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare China Resources Boya Bio pharmaceutical Group Co Ltd to the Biotechnology industry mean.
  • A PE ratio of -18.74 means the investor is paying ¥-18.74 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of China Resources Boya Bio pharmaceutical Group Co Ltd:

  • The EOD is -17.240. Based on the earnings, the company is expensive. -2
  • The MRQ is -18.737. Based on the earnings, the company is expensive. -2
  • The TTM is 16.243. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-17.240MRQ-18.737+1.496
MRQ-18.737TTM16.243-34.979
TTM16.243YOY29.552-13.309
TTM16.2435Y49.339-33.096
5Y49.33910Y92.490-43.151
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-17.240-2.315-14.925
MRQ-18.737-2.560-16.177
TTM16.243-2.664+18.907
YOY29.552-4.122+33.674
5Y49.339-6.258+55.597
10Y92.490-6.108+98.598
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of China Resources Boya Bio pharmaceutical Group Co Ltd:

  • The EOD is 37.900. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 41.190. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 32.753. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD37.900MRQ41.190-3.290
MRQ41.190TTM32.753+8.437
TTM32.753YOY118.757-86.005
TTM32.7535Y37.591-4.838
5Y37.59110Y3.400+34.192
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD37.900-3.067+40.967
MRQ41.190-3.251+44.441
TTM32.753-3.545+36.298
YOY118.757-5.595+124.352
5Y37.591-8.315+45.906
10Y3.400-8.708+12.108
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of China Resources Boya Bio pharmaceutical Group Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.32 means the investor is paying ¥2.32 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of China Resources Boya Bio pharmaceutical Group Co Ltd:

  • The EOD is 2.135. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.320. Based on the equity, the company is underpriced. +1
  • The TTM is 2.303. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.135MRQ2.320-0.185
MRQ2.320TTM2.303+0.016
TTM2.303YOY2.359-0.056
TTM2.3035Y3.288-0.984
5Y3.28810Y10.130-6.842
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.1351.905+0.230
MRQ2.3202.111+0.209
TTM2.3032.095+0.208
YOY2.3592.836-0.477
5Y3.2883.443-0.155
10Y10.1303.794+6.336
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of China Resources Boya Bio pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.5000.018-2899%0.230-317%0.352-242%0.321-256%
Book Value Per Share--14.51814.775-2%14.185+2%10.939+33%7.417+96%
Current Ratio--14.08211.006+28%8.955+57%6.305+123%3.410+313%
Debt To Asset Ratio--0.0650.079-18%0.090-28%0.158-59%0.163-60%
Debt To Equity Ratio--0.0690.087-20%0.100-31%0.200-65%0.212-67%
Dividend Per Share----0%0.041-100%0.030-100%0.051-100%
Eps---0.4490.118-482%0.291-254%0.184-344%0.159-382%
Free Cash Flow Per Share--0.2040.275-26%0.227-10%0.264-22%0.152+34%
Free Cash Flow To Equity Per Share--0.2040.263-22%0.185+11%0.389-47%0.308-34%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--6.488--------
Intrinsic Value_10Y_min--5.936--------
Intrinsic Value_1Y_max--1.389--------
Intrinsic Value_1Y_min--1.365--------
Intrinsic Value_3Y_max--3.610--------
Intrinsic Value_3Y_min--3.458--------
Intrinsic Value_5Y_max--5.153--------
Intrinsic Value_5Y_min--4.831--------
Market Cap15626676262.080-9%16983106050.56017154550707.840-1%16940387642.160+0%16875266020.885+1%20506963738.700-17%
Net Profit Margin---0.4910.036-1456%0.155-418%0.112-538%0.181-371%
Operating Margin---0.098-100%0.183-100%0.153-100%0.094-100%
Operating Ratio--1.0801.245-13%1.265-15%1.263-14%0.858+26%
Pb Ratio2.135-9%2.3202.303+1%2.359-2%3.288-29%10.130-77%
Pe Ratio-17.240+8%-18.73716.243-215%29.552-163%49.339-138%92.490-120%
Price Per Share30.990-9%33.68034.020-1%33.488+1%33.417+1%40.644-17%
Price To Free Cash Flow Ratio37.900-9%41.19032.753+26%118.757-65%37.591+10%3.400+1112%
Price To Total Gains Ratio-62.039+8%-67.424137.807-149%298.758-123%163.379-141%278.866-124%
Quick Ratio--7.8266.507+20%6.160+27%3.414+129%2.212+254%
Return On Assets---0.0290.007-517%0.014-310%0.014-308%0.021-239%
Return On Equity---0.0310.008-493%0.015-302%0.017-278%0.026-218%
Total Gains Per Share---0.5000.018-2899%0.271-284%0.382-231%0.372-234%
Usd Book Value--1011738084.0131029632678.467-2%991990601.895+2%763715950.130+32%517569207.161+95%
Usd Book Value Change Per Share---0.0690.002-2899%0.032-317%0.049-242%0.044-256%
Usd Book Value Per Share--2.0062.042-2%1.960+2%1.512+33%1.025+96%
Usd Dividend Per Share----0%0.006-100%0.004-100%0.007-100%
Usd Eps---0.0620.016-482%0.040-254%0.025-344%0.022-382%
Usd Free Cash Flow--14245470.93119148693.382-26%15824817.241-10%18397630.996-23%8756591.315+63%
Usd Free Cash Flow Per Share--0.0280.038-26%0.031-10%0.036-22%0.021+34%
Usd Free Cash Flow To Equity Per Share--0.0280.036-22%0.026+11%0.054-47%0.043-34%
Usd Market Cap2159606659.419-9%2347065256.1872370758907.823-1%2341161572.147+0%2332161764.086+1%2834062388.688-17%
Usd Price Per Share4.283-9%4.6554.702-1%4.628+1%4.618+1%5.617-17%
Usd Profit---31316424.7018204436.268-482%14932425.490-310%11749757.572-367%10552201.138-397%
Usd Revenue--63790444.05491625891.955-30%95313130.437-33%94678856.773-33%67515627.580-6%
Usd Total Gains Per Share---0.0690.002-2899%0.038-284%0.053-231%0.051-234%
 EOD+4 -4MRQTTM+7 -26YOY+16 -195Y+13 -2210Y+13 -22

3.2. Fundamental Score

Let's check the fundamental score of China Resources Boya Bio pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-17.240
Price to Book Ratio (EOD)Between0-12.135
Net Profit Margin (MRQ)Greater than0-0.491
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than17.826
Current Ratio (MRQ)Greater than114.082
Debt to Asset Ratio (MRQ)Less than10.065
Debt to Equity Ratio (MRQ)Less than10.069
Return on Equity (MRQ)Greater than0.15-0.031
Return on Assets (MRQ)Greater than0.05-0.029
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of China Resources Boya Bio pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.598
Ma 20Greater thanMa 5029.196
Ma 50Greater thanMa 10028.333
Ma 100Greater thanMa 20030.439
OpenGreater thanClose30.710
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income before Tax  27,973177,829205,803-18,014187,788-6,177181,611-403,101-221,490
Net Income  13,918156,399170,317-14,717155,601-17,452138,149-364,752-226,602
Net Income from Continuing Operations  16,589157,784174,373-16,119158,254-16,791141,462-367,403-225,941



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,828,900
Total Liabilities508,075
Total Stockholder Equity7,319,751
 As reported
Total Liabilities 508,075
Total Stockholder Equity+ 7,319,751
Total Assets = 7,828,900

Assets

Total Assets7,828,900
Total Current Assets6,427,633
Long-term Assets1,401,267
Total Current Assets
Cash And Cash Equivalents 1,961,479
Short-term Investments 3,362,461
Net Receivables 209,837
Inventory 556,940
Other Current Assets 1,766
Total Current Assets  (as reported)6,427,633
Total Current Assets  (calculated)6,092,483
+/- 335,150
Long-term Assets
Property Plant Equipment 676,619
Goodwill 72,613
Intangible Assets 322,535
Long-term Assets Other 146,182
Long-term Assets  (as reported)1,401,267
Long-term Assets  (calculated)1,217,949
+/- 183,318

Liabilities & Shareholders' Equity

Total Current Liabilities456,447
Long-term Liabilities51,628
Total Stockholder Equity7,319,751
Total Current Liabilities
Accounts payable 126,350
Other Current Liabilities 1,194
Total Current Liabilities  (as reported)456,447
Total Current Liabilities  (calculated)127,544
+/- 328,903
Long-term Liabilities
Long term Debt 22,145
Capital Lease Obligations Min Short Term Debt1,403
Long-term Liabilities  (as reported)51,628
Long-term Liabilities  (calculated)23,548
+/- 28,080
Total Stockholder Equity
Retained Earnings 2,500,380
Total Stockholder Equity (as reported)7,319,751
Total Stockholder Equity (calculated)2,500,380
+/- 4,819,370
Other
Capital Stock504,249
Common Stock Shares Outstanding 504,249
Net Invested Capital 7,341,896
Net Working Capital 5,971,186
Property Plant and Equipment Gross 676,619



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312010-12-312009-12-31
> Total Assets 
316,428
295,226
331,154
777,891
734,839
760,629
777,406
762,945
787,757
836,019
1,004,470
939,924
929,396
967,862
1,017,832
1,050,973
1,095,499
1,129,980
2,188,216
2,154,581
2,216,635
2,275,471
2,419,482
2,773,145
2,906,130
2,971,884
3,669,635
3,773,319
5,141,441
5,192,537
5,073,150
5,024,152
5,067,035
5,176,590
5,256,691
5,521,881
5,408,338
5,317,294
5,158,535
5,005,101
5,281,425
5,423,625
7,621,776
7,679,391
7,850,810
7,979,553
8,033,175
8,196,384
8,167,575
8,182,959
7,828,900
7,828,9008,182,9598,167,5758,196,3848,033,1757,979,5537,850,8107,679,3917,621,7765,423,6255,281,4255,005,1015,158,5355,317,2945,408,3385,521,8815,256,6915,176,5905,067,0355,024,1525,073,1505,192,5375,141,4413,773,3193,669,6352,971,8842,906,1302,773,1452,419,4822,275,4712,216,6352,154,5812,188,2161,129,9801,095,4991,050,9731,017,832967,862929,396939,9241,004,470836,019787,757762,945777,406760,629734,839777,891331,154295,226316,428
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,055,173
3,086,418
3,046,890
2,995,753
3,041,649
3,126,503
3,052,983
3,187,385
3,216,000
3,127,134
2,927,663
2,760,475
3,012,296
3,354,783
5,645,913
5,720,245
5,897,376
5,991,276
6,073,386
6,239,082
6,188,780
6,379,272
6,427,633
6,427,6336,379,2726,188,7806,239,0826,073,3865,991,2765,897,3765,720,2455,645,9133,354,7833,012,2962,760,4752,927,6633,127,1343,216,0003,187,3853,052,9833,126,5033,041,6492,995,7533,046,8903,086,4183,055,1730000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
832,730
723,944
1,193,392
730,280
659,422
588,441
568,749
678,422
533,458
601,742
753,894
668,822
723,852
1,083,130
1,583,695
891,968
1,007,129
1,099,156
1,531,619
1,711,056
1,941,279
1,342,767
1,961,479
1,961,4791,342,7671,941,2791,711,0561,531,6191,099,1561,007,129891,9681,583,6951,083,130723,852668,822753,894601,742533,458678,422568,749588,441659,422730,2801,193,392723,944832,7300000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
785,000
0
0
0
201,000
0
0
0
111,000
100,000
0
0
948,500
940,000
2,700,000
3,400,000
3,450,000
3,491,264
3,193,912
3,224,390
3,047,838
3,766,881
3,362,461
3,362,4613,766,8813,047,8383,224,3903,193,9123,491,2643,450,0003,400,0002,700,000940,000948,50000100,000111,000000201,000000785,0000000000000000000000000000000
       Net Receivables 
31,012
14,714
10,888
11,652
10,742
7,633
7,296
9,270
23,735
13,955
87,056
91,098
68,386
83,640
96,730
107,076
103,200
95,087
134,897
122,379
161,739
183,187
237,748
244,413
317,337
387,376
583,148
700,062
704,905
752,412
906,576
653,121
687,407
704,829
1,009,455
993,286
1,053,537
937,597
734,223
703,911
655,852
690,343
655,978
733,656
775,649
736,605
461,706
677,552
457,522
258,065
209,837
209,837258,065457,522677,552461,706736,605775,649733,656655,978690,343655,852703,911734,223937,5971,053,537993,2861,009,455704,829687,407653,121906,576752,412704,905700,062583,148387,376317,337244,413237,748183,187161,739122,379134,89795,087103,200107,07696,73083,64068,38691,09887,05613,95523,7359,2707,2967,63310,74211,65210,88814,71431,012
       Other Current Assets 
29,874
1,064
4,500
10,052
5,348
1,767
2,097
5,504
5,449
8,248
16,162
8,542
14,568
17,144
32,484
6,042
2,925
2,929
6,772
24,919
7,121
75,550
12,077
60,064
118,412
164,704
151,233
141,511
191,441
1,022,525
342,490
225,373
17,469
17,154
853,379
853,285
859,097
788,433
750,082
700,326
26,191
27,889
29,404
24,313
4,307
7,324
3,592
8,265
1,245
638
1,766
1,7666381,2458,2653,5927,3244,30724,31329,40427,88926,191700,326750,082788,433859,097853,285853,37917,15417,469225,373342,4901,022,525191,441141,511151,233164,704118,41260,06412,07775,5507,12124,9196,7722,9292,9256,04232,48417,14414,5688,54216,1628,2485,4495,5042,0971,7675,34810,0524,5001,06429,874
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,028,399
2,025,386
2,050,087
2,203,707
2,334,496
2,192,339
2,190,160
2,230,872
2,244,626
2,269,129
2,068,842
1,975,863
1,959,146
1,953,434
1,988,278
1,959,789
1,957,302
1,978,795
1,803,687
1,401,267
1,401,2671,803,6871,978,7951,957,3021,959,7891,988,2781,953,4341,959,1461,975,8632,068,8422,269,1292,244,6262,230,8722,190,1602,192,3392,334,4962,203,7072,050,0872,025,3862,028,3990000000000000000000000000000000
       Property Plant Equipment 
99,841
140,327
151,869
137,185
153,940
146,193
157,522
144,803
158,879
143,115
212,560
185,977
181,334
184,557
188,760
223,456
215,720
257,816
432,631
436,559
481,746
517,426
579,602
599,843
629,838
656,511
728,316
756,962
802,779
820,367
855,027
843,679
834,087
829,815
814,801
813,439
814,520
808,666
809,519
806,768
800,790
795,779
771,332
767,750
753,154
747,683
722,811
720,878
719,949
711,812
676,619
676,619711,812719,949720,878722,811747,683753,154767,750771,332795,779800,790806,768809,519808,666814,520813,439814,801829,815834,087843,679855,027820,367802,779756,962728,316656,511629,838599,843579,602517,426481,746436,559432,631257,816215,720223,456188,760184,557181,334185,977212,560143,115158,879144,803157,522146,193153,940137,185151,869140,32799,841
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
126,748
126,748
126,748
126,748
126,748
126,748
126,748
497,774
497,774
497,774
497,774
497,774
497,774
497,774
497,774
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
663,842
497,774
72,613
72,613497,774663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842663,842497,774497,774497,774497,774497,774497,774497,774497,774126,748126,748126,748126,748126,748126,748126,74800000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
245,549
245,581
144,163
143,083
142,004
142,205
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000142,205142,004143,083144,163245,581245,5490000000000000000000000000000
       Intangible Assets 
12,719
12,698
160
13,050
372
13,098
329
12,902
286
12,706
10,940
158,912
158,491
157,978
159,597
159,865
182,029
181,263
595,856
595,049
593,880
592,764
591,764
590,859
623,226
622,215
778,007
776,633
116,600
128,833
163,351
238,179
136,165
270,775
280,714
281,141
286,783
290,541
315,502
317,774
326,044
336,585
272,752
273,867
278,332
314,364
350,057
349,932
365,993
368,262
322,535
322,535368,262365,993349,932350,057314,364278,332273,867272,752336,585326,044317,774315,502290,541286,783281,141280,714270,775136,165238,179163,351128,833116,600776,633778,007622,215623,226590,859591,764592,764593,880595,049595,856181,263182,029159,865159,597157,978158,491158,91210,94012,70628612,90232913,09837213,05016012,69812,719
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
64,746
57,648
72,029
229,101
364,530
45,400
860,348
60,273
68,082
55,779
42,554
37,199
34,706
43,002
52,504
15,542
20,662
20,368
20,256
146,182
146,18220,25620,36820,66215,54252,50443,00234,70637,19942,55455,77968,08260,273860,34845,400364,530229,10172,02957,64864,7460000000000000000000000000000000
> Total Liabilities 
151,934
97,789
68,483
66,094
24,545
29,589
25,802
32,300
35,904
65,322
157,845
72,015
72,060
79,664
93,903
77,950
140,321
135,069
280,108
207,210
253,919
237,422
287,297
572,213
639,661
637,609
1,185,331
1,198,878
1,571,299
1,562,885
1,302,615
1,304,719
1,294,575
1,299,050
1,268,104
1,433,405
1,322,722
1,164,563
966,078
708,747
887,274
901,590
701,300
652,063
719,463
711,316
748,349
771,237
685,024
610,247
508,075
508,075610,247685,024771,237748,349711,316719,463652,063701,300901,590887,274708,747966,0781,164,5631,322,7221,433,4051,268,1041,299,0501,294,5751,304,7191,302,6151,562,8851,571,2991,198,8781,185,331637,609639,661572,213287,297237,422253,919207,210280,108135,069140,32177,95093,90379,66472,06072,015157,84565,32235,90432,30025,80229,58924,54566,09468,48397,789151,934
   > Total Current Liabilities 
55,434
52,339
23,633
21,394
19,995
25,189
21,552
28,200
31,954
61,522
150,270
65,362
65,677
73,547
86,862
72,834
133,822
106,671
243,819
169,758
216,819
200,276
249,747
264,781
332,340
331,324
716,158
629,619
942,795
934,757
807,069
886,747
927,768
923,361
956,509
1,122,847
1,142,151
984,964
871,928
662,698
816,590
832,259
630,941
605,221
673,452
665,731
705,337
729,980
623,511
556,270
456,447
456,447556,270623,511729,980705,337665,731673,452605,221630,941832,259816,590662,698871,928984,9641,142,1511,122,847956,509923,361927,768886,747807,069934,757942,795629,619716,158331,324332,340264,781249,747200,276216,819169,758243,819106,671133,82272,83486,86273,54765,67765,362150,27061,52231,95428,20021,55225,18919,99521,39423,63352,33955,434
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,145
0
61,500
193,350
293,350
200,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000200,000293,350193,35061,500022,1450000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,145
0
61,500
193,350
293,350
200,000
256,833
421,004
420,886
310,729
220,197
10,011
239,905
239,934
0
0
0
0
0
0
0
0
0
000000000239,934239,90510,011220,197310,729420,886421,004256,833200,000293,350193,35061,500022,1450000000000000000000000000000
       Accounts payable 
21,476
9,034
8,780
7,288
8,211
7,469
8,097
11,110
13,634
13,283
14,827
11,980
13,307
12,869
12,321
13,710
21,836
19,853
107,216
85,088
92,218
87,713
88,365
104,476
162,629
174,822
178,829
274,068
217,336
223,753
277,554
310,629
247,208
377,833
250,673
294,701
349,754
286,713
285,883
241,963
263,513
251,740
277,529
303,770
339,582
298,361
303,458
314,943
229,510
140,921
126,350
126,350140,921229,510314,943303,458298,361339,582303,770277,529251,740263,513241,963285,883286,713349,754294,701250,673377,833247,208310,629277,554223,753217,336274,068178,829174,822162,629104,47688,36587,71392,21885,088107,21619,85321,83613,71012,32112,86913,30711,98014,82713,28313,63411,1108,0977,4698,2117,2888,7809,03421,476
       Other Current Liabilities 
33,958
16,805
14,853
14,106
11,784
17,720
13,455
17,090
18,320
48,239
135,443
53,383
52,370
60,678
74,541
59,123
66,986
63,818
113,602
84,670
94,601
112,563
161,383
150,305
169,711
156,501
460,184
278,406
207,461
331,335
133,498
50,000
72,000
32,000
77,868
259,421
146,228
242,378
66,095
263,133
80,539
239,148
256,498
243,718
78,035
287,487
2,350
327,365
64,135
1,221
1,194
1,1941,22164,135327,3652,350287,48778,035243,718256,498239,14880,539263,13366,095242,378146,228259,42177,86832,00072,00050,000133,498331,335207,461278,406460,184156,501169,711150,305161,383112,56394,60184,670113,60263,81866,98659,12374,54160,67852,37053,383135,44348,23918,32017,09013,45517,72011,78414,10614,85316,80533,958
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
417,972
366,807
375,689
311,595
310,557
180,570
179,599
94,150
46,048
70,685
69,331
70,359
46,842
46,011
45,584
43,012
41,256
61,513
53,977
51,628
51,62853,97761,51341,25643,01245,58446,01146,84270,35969,33170,68546,04894,150179,599180,570310,557311,595375,689366,807417,9720000000000000000000000000000000
       Other Liabilities 
0
5,450
4,850
4,700
4,550
4,400
4,250
4,100
3,950
3,800
3,650
3,500
3,350
3,200
4,240
2,900
3,940
3,790
5,161
6,374
6,458
6,710
6,939
7,001
7,070
6,212
11,369
11,267
18,504
18,128
45,546
44,972
44,307
43,189
42,595
41,557
40,570
39,599
39,150
38,161
37,430
36,434
36,913
36,001
34,851
33,702
32,643
31,500
0
0
0
00031,50032,64333,70234,85136,00136,91336,43437,43038,16139,15039,59940,57041,55742,59543,18944,30744,97245,54618,12818,50411,26711,3696,2127,0707,0016,9396,7106,4586,3745,1613,7903,9402,9004,2403,2003,3503,5003,6503,8003,9504,1004,2504,4004,5504,7004,8505,4500
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
115,877
121,452
128,445
126,766
137,542
145,221
161,006
162,457
159,988
165,425
166,405
168,567
191,059
200,474
161,616
161,886
165,517
94,717
82,638
84,903
0
0
0
00084,90382,63894,717165,517161,886161,616200,474191,059168,567166,405165,425159,988162,457161,006145,221137,542126,766128,445121,452115,8770000000000000000000000000000
> Total Stockholder Equity
164,495
197,437
262,671
711,797
710,294
731,040
751,604
730,645
751,853
770,698
792,107
811,804
798,666
825,183
858,387
903,610
883,580
917,238
1,874,832
1,913,372
1,927,087
2,001,068
2,093,397
2,160,853
2,224,399
2,290,214
2,425,746
2,495,465
3,488,167
3,562,780
3,704,660
3,650,485
3,698,751
3,804,012
3,911,735
4,007,638
4,008,956
4,071,714
4,107,904
4,208,580
4,310,716
4,435,637
6,829,074
6,932,628
7,032,275
7,171,716
7,185,634
7,355,952
7,410,703
7,551,702
7,319,751
7,319,7517,551,7027,410,7037,355,9527,185,6347,171,7167,032,2756,932,6286,829,0744,435,6374,310,7164,208,5804,107,9044,071,7144,008,9564,007,6383,911,7353,804,0123,698,7513,650,4853,704,6603,562,7803,488,1672,495,4652,425,7462,290,2142,224,3992,160,8532,093,3972,001,0681,927,0871,913,3721,874,832917,238883,580903,610858,387825,183798,666811,804792,107770,698751,853730,645751,604731,040710,294711,797262,671197,437164,495
   Common Stock
56,780
56,780
56,780
75,800
75,800
75,800
75,800
75,800
75,800
75,800
75,800
75,800
75,800
75,800
75,800
75,800
113,700
227,400
267,385
267,385
267,385
267,385
267,385
267,385
401,077
401,077
401,077
401,077
433,325
433,325
433,325
433,325
433,325
433,325
433,325
433,325
433,325
433,325
433,325
433,325
433,325
433,325
511,633
511,633
504,249
504,249
504,249
504,249
0
0
0
000504,249504,249504,249504,249511,633511,633433,325433,325433,325433,325433,325433,325433,325433,325433,325433,325433,325433,325433,325433,325401,077401,077401,077401,077267,385267,385267,385267,385267,385267,385227,400113,70075,80075,80075,80075,80075,80075,80075,80075,80075,80075,80075,80075,80075,80056,78056,78056,780
   Retained Earnings 
36,848
64,581
122,992
139,381
137,878
158,625
171,526
150,567
171,776
190,620
207,027
264,824
251,728
278,245
311,449
356,673
336,643
370,300
417,768
456,308
470,023
544,003
636,333
703,788
767,335
833,150
966,183
1,038,711
1,092,147
1,182,549
1,370,359
1,319,116
1,378,079
1,483,340
1,731,507
1,827,410
1,828,728
1,891,486
1,927,676
2,028,412
2,097,755
2,238,308
2,259,329
2,362,883
2,462,530
2,601,971
2,615,889
2,786,206
2,588,833
2,726,983
2,500,380
2,500,3802,726,9832,588,8332,786,2062,615,8892,601,9712,462,5302,362,8832,259,3292,238,3082,097,7552,028,4121,927,6761,891,4861,828,7281,827,4101,731,5071,483,3401,378,0791,319,1161,370,3591,182,5491,092,1471,038,711966,183833,150767,335703,788636,333544,003470,023456,308417,768370,300336,643356,673311,449278,245251,728264,824207,027190,620171,776150,567171,526158,625137,878139,381122,99264,58136,848
   Capital Surplus 000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-60
32,733
17,100
0
0
0
0
0
0
0
0
0
00000000017,10032,733-60000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,651,980
Cost of Revenue-1,252,861
Gross Profit1,399,1191,399,119
 
Operating Income (+$)
Gross Profit1,399,119
Operating Expense-2,093,115
Operating Income558,864-693,996
 
Operating Expense (+$)
Research Development67,696
Selling General Administrative633,090
Selling And Marketing Expenses0
Operating Expense2,093,115700,786
 
Net Interest Income (+$)
Interest Income31,293
Interest Expense-456
Other Finance Cost-345
Net Interest Income30,493
 
Pretax Income (+$)
Operating Income558,864
Net Interest Income30,493
Other Non-Operating Income Expenses0
Income Before Tax (EBT)353,712558,864
EBIT - interestExpense = -456
237,466
237,921
Interest Expense456
Earnings Before Interest and Taxes (EBIT)0354,167
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax353,712
Tax Provision-105,563
Net Income From Continuing Ops248,148248,148
Net Income237,466
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-30,493
 

Technical Analysis of China Resources Boya Bio pharmaceutical Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of China Resources Boya Bio pharmaceutical Group Co Ltd. The general trend of China Resources Boya Bio pharmaceutical Group Co Ltd is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine China Resources Boya Bio pharmaceutical Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of China Resources Boya Bio pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 31.08 < 31.75 < 32.46.

The bearish price targets are: 29.68 > 29.34 > 29.06.

Tweet this
China Resources Boya Bio pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of China Resources Boya Bio pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

China Resources Boya Bio pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of China Resources Boya Bio pharmaceutical Group Co Ltd. The current macd is 0.69510974.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the China Resources Boya Bio pharmaceutical Group Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for China Resources Boya Bio pharmaceutical Group Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the China Resources Boya Bio pharmaceutical Group Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
China Resources Boya Bio pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartChina Resources Boya Bio pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of China Resources Boya Bio pharmaceutical Group Co Ltd. The current adx is 16.88.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy China Resources Boya Bio pharmaceutical Group Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
China Resources Boya Bio pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of China Resources Boya Bio pharmaceutical Group Co Ltd. The current sar is 29.23.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
China Resources Boya Bio pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of China Resources Boya Bio pharmaceutical Group Co Ltd. The current rsi is 62.60. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
China Resources Boya Bio pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartChina Resources Boya Bio pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of China Resources Boya Bio pharmaceutical Group Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the China Resources Boya Bio pharmaceutical Group Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
China Resources Boya Bio pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartChina Resources Boya Bio pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of China Resources Boya Bio pharmaceutical Group Co Ltd. The current cci is 114.12.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
China Resources Boya Bio pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartChina Resources Boya Bio pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of China Resources Boya Bio pharmaceutical Group Co Ltd. The current cmo is 32.26.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
China Resources Boya Bio pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartChina Resources Boya Bio pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of China Resources Boya Bio pharmaceutical Group Co Ltd. The current willr is -18.93203883.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
China Resources Boya Bio pharmaceutical Group Co Ltd Daily Williams %R ChartChina Resources Boya Bio pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of China Resources Boya Bio pharmaceutical Group Co Ltd.

China Resources Boya Bio pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of China Resources Boya Bio pharmaceutical Group Co Ltd. The current atr is 1.01499572.

China Resources Boya Bio pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartChina Resources Boya Bio pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of China Resources Boya Bio pharmaceutical Group Co Ltd. The current obv is 60,079,033.

China Resources Boya Bio pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartChina Resources Boya Bio pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of China Resources Boya Bio pharmaceutical Group Co Ltd. The current mfi is 70.47.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
China Resources Boya Bio pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartChina Resources Boya Bio pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for China Resources Boya Bio pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

China Resources Boya Bio pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of China Resources Boya Bio pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.598
Ma 20Greater thanMa 5029.196
Ma 50Greater thanMa 10028.333
Ma 100Greater thanMa 20030.439
OpenGreater thanClose30.710
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of China Resources Boya Bio pharmaceutical Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on China Resources Boya Bio pharmaceutical Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about China Resources Boya Bio pharmaceutical Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about China Resources Boya Bio pharmaceutical Group Co Ltd

I send you an email if I find something interesting about China Resources Boya Bio pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about China Resources Boya Bio pharmaceutical Group Co Ltd.

Receive notifications about China Resources Boya Bio pharmaceutical Group Co Ltd in your mailbox!